87 / 112
85
WFSBP 2015
Thursday, 18 June 2015
|
Scientific Programme
P-23
Poster Presentation
12:45–14:15
Muses Foyer
Schizophrenia
Chair:
Elias Angelopoulos, Greece
Co-Chair: Dimitra Pappa, Greece
P-23-001
Bridging the gap between biochemistry content and sensory
process in schizophrenia and schizoaffective psychosis
Stephanie Fryar-Williams, Australia
P-23-002
Development of a novel animal model of clozapine-resistant
schizophrenia: Behavioral and neurobiological character-
ization
Michal Taler, Israel
I. Gil-Ad, I. Tarasenko, A. Weizman, A. Krivoy
P-23-004
Frequency and type of somatic diseases in schizophrenic
patients–correlation with antipsychotics treatment
Dzevad Begic, Bosnia and Herzegovina
S. Bise, O. Cemalovic, B. Kurtovic
P-23-006
Memory deficits in a ketamine-induced rat model of schizo
phrenia
Manuela Padurariu, Romania
M. Paulet, L. Hritcu, A. Ciobica, R. Lefter, D. Timofte
P-23-007
Myelination alterations in an animal model of schizophre-
nia-like symptoms and schizophrenia patients
Michaela Filiou, Germany
P. Wood, L. Teplytska, D. Otte, A. Zimmer, C. Turck
P-23-008
Neurological soft signs might be an endophenotype can-
didate for patients with deficit syndrome schizophrenia
Murat Beyazyüz, Turkey
E. Soydas Akyol, Y. Albayrak, M. Kuloglu
P-23-009
Re-engineering case management processes to promote
patients adherence to treatment
Margaret Mary Hendricks, Singapore
V. K. Swapna, K. L. Yow
P-23-011
Cognitive profile in schizophrenia and bipolar disorder:
A study in Chilean patients
Aida Ruiz, Chile
M. Martinez, A. Soto, E. Miranda
P-23-013
Frontal assessment battery (fab). A brief assessment of
executive functions in schizophrenic patients
John Nimatoudis, Greece
A. Theofilidis
P-23-014
Paliperidone for the treatment of schizoaffective disorder
Christos Istikoglou, Greece
R. Malamou, E. Liapis, A. Aivatides, M. Economou, M. Vassi-
liadou, N. Polonifis, P. Kanellos, I. Liappas, D. Vlissides
P-23-016
Reduced negative symptoms may distinguish the clinical
profile of patients with psychosis following traumatic brain
injury from schizophrenia/schizoaffective disorder
Rachel Batty, Australia
A. Francis, N. Thomas, M. Hopwood, J. Ponsford, S. Rossell
P-23-017
Smoking habits in psychotic patients in Greek population
Christos Istikoglou, Greece
E. Liapis, A. Aivatides, M. Economou, M. Vassiliadou, P. Ka-
nellos, N. Polofinis, I. Liappas, R. Malamou, V. Tziora
P-23-018
Social cognition in people with schizophrenia as seen in
thematic apperception test
Ladislav Hosak, Czech Republic
K. Hosakova, M. Lecbych
P-23-020
Treatment in first psychotic episodes: A case report
Esteban Rodríguez Jiménez, Spain
J. Alcalá Partera, M. d. Pino Ordovás González
P-23-021
International classification of functioning, disability and
health (ICF) for schizophrenic patients
Oscar Pino, Spain
E. Rojo, G. Guilera, J. Gomez-Benito